Friedrich Thaiss Selected Research

Friedrich Thaiss Research Topics

Disease

11	Inflammation (Inflammations) 01/2017 - 06/2002
7	Nephritis 01/2019 - 03/2002
6	Glomerulonephritis 01/2019 - 03/2002
5	Proteinuria 01/2016 - 12/2007
4	Hypertension (High Blood Pressure) 06/2006 - 03/2002
3	Infections 01/2021 - 06/2007
3	Reperfusion Injury 07/2017 - 01/2013
3	Neoplasms (Cancer) 07/2017 - 06/2007
2	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2012 - 05/2011
2	Hypertrophy 10/2012 - 06/2002
2	Renal Insufficiency (Renal Failure) 12/2009 - 05/2009
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2008 - 12/2007
1	Hepatocellular Carcinoma (Hepatoma) 07/2017
1	Lymphatic Metastasis 07/2017
1	Prostatic Neoplasms (Prostate Cancer) 06/2017
1	Ischemia 01/2017
1	Delayed Graft Function 01/2017
1	Brain Death (Brain Dead) 12/2016
1	Viremia 12/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Body Weight (Weight, Body) 01/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012
1	Edema (Dropsy) 09/2011
1	Hypercholesterolemia 09/2011
1	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2011
1	Hypoalbuminemia 09/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011
1	Kidney Diseases (Kidney Disease) 12/2009
1	Chronic Renal Insufficiency 05/2009
1	Herpes Simplex 06/2007
1	Colonic Neoplasms (Colon Cancer) 06/2007

Drug/Important Bio-Agent (IBA)

7	ChemokinesIBA 01/2016 - 10/2002
4	Proteins (Proteins, Gene)FDA Link 07/2017 - 08/2009
4	NF-kappa B (NF-kB)IBA 08/2009 - 06/2002
3	LipopolysaccharidesIBA 08/2009 - 10/2002
3	Chemokine CCL5IBA 05/2009 - 10/2002
2	Everolimus FDA Link 01/2021 - 01/2013
2	CreatinineIBA 01/2016 - 12/2007
2	rho-Associated KinasesIBA 10/2012 - 05/2009
2	Antigen-Antibody Complex (Immune Complex)IBA 10/2012 - 09/2011
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2009 - 05/2009
2	LigandsIBA 08/2009 - 06/2006
2	anti-Thy antibodyIBA 08/2009 - 06/2002
2	Angiotensin IIIBA 05/2009 - 03/2002
2	Rituximab (Mabthera)FDA Link 11/2008 - 12/2007
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2006 - 03/2002
1	AcidsIBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Phosphotransferases (Kinase)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	p38 Mitogen-Activated Protein KinasesIBA 06/2017
1	Purinergic P1 Receptor AgonistsIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Isoantigens (Alloantigen)IBA 01/2017
1	AntibodiesIBA 02/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2016
1	SteroidsIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Chemokine ReceptorsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	Interleukin-1 (Interleukin 1)IBA 11/2012
1	Periodic AcidIBA 10/2012
1	Antinuclear AntibodiesIBA 04/2012
1	Triglycerides (Triacylglycerol)IBA 09/2011
1	UbiquitinIBA 05/2011
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2011
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 05/2011
1	Ubiquitin CIBA 05/2011
1	Peptide Hydrolases (Proteases)FDA Link 05/2011
1	PolyubiquitinIBA 05/2011
1	HydrolasesIBA 05/2011
1	ProstaglandinsIBA 08/2009
1	cysteinylcysteineIBA 08/2009
1	Fibronectins (Fibronectin)IBA 05/2009
1	Type 2 Angiotensin ReceptorIBA 05/2009
1	Etoposide (VP 16)FDA LinkGeneric 06/2007
1	Interleukin-12 (IL 12)IBA 06/2007
1	Doxycycline (Periostat)FDA LinkGeneric 06/2007
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 06/2007
1	Trans-Activators (Trans-Acting Factor)IBA 06/2007
1	CytokinesIBA 06/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2005
1	CC ChemokinesIBA 10/2002
1	PPAR gammaIBA 08/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2002
1	Irbesartan FDA LinkGeneric 03/2002
1	PD 123319IBA 03/2002
1	Peptides (Polypeptides)IBA 03/2002

Therapy/Procedure

3	Kidney Transplantation 01/2017 - 12/2009
3	Therapeutics 01/2017 - 12/2007
2	Transplantation 12/2016 - 12/2007
1	Hepatectomy 07/2017
1	Injections 06/2002